论文部分内容阅读
随着我国对外开放和保护知识产权的形势发展,实行药品专利势在必行。现今,国外创制一个新药通常需化10年多时间。鉴于人力、物力、财力的限制,我国还需略长些。因而,既使我国延至2000年实行药品专利,亦必须尽早抓紧研究专利与药品市场的关系及制定战略规划。1 专利与药品绝对垄断权在实行药物品种专利的国家内,研究人员发现一个有效药理作用的新化合物后,通常由制药公司先向本国专利局申请品种专利。在一定的年限内,凭专利保护使新药在生产和销售等方面有绝对的垄断权。稍后,又以不同的处方、新剂型、新释药系统或药物的多
With the opening up of our country and the development of intellectual property protection, the implementation of pharmaceutical patents is imperative. Today, creating a new drug abroad usually takes more than 10 years. Given the constraints of manpower, material and financial resources, our country still needs a bit longer. Therefore, even if China delays the implementation of drug patents by the year 2000, it must step up its research on the relationship between the patent and drug markets and formulate strategic plans as soon as possible. 1. Absolute monopoly power of patents and medicines In countries where patents on pharmaceutical products are available, researchers often apply for a patent for a variety of patents to a national patent office before the discovery of a new pharmacologically effective compound. Within a certain number of years, with the patent protection so that new drugs in the production and sale of absolute monopoly power. Later, again with different prescriptions, new dosage forms, new drug delivery system or more drugs